Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for McKesson Corporation (MCK : NYSE)
 
 • Company Description   
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.

Number of Employees: 45,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $705.45 Daily Weekly Monthly
20 Day Moving Average: 728,786 shares
Shares Outstanding: 125.11 (millions)
Market Capitalization: $88,260.43 (millions)
Beta: 0.48
52 Week High: $736.96
52 Week Low: $464.42
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.57% -4.66%
12 Week 5.02% -7.98%
Year To Date 23.78% 16.91%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
6555 STATE HIGHWAY 161
-
IRVING,TX 75039
USA
ph: 972-446-4800
fax: 415-983-8453
investors@mckesson.com http://www.mckesson.com
 
 • General Corporate Information   
Officers
Brian S. Tyler - Chief Executive Officer and Director
Britt J. Vitalone - Executive Vice President and Chief Financial Offic
Napoleon B. Rutledge Jr. - Senior Vice President and Controller
James H. Hinton - Director
Donald R. Knauss - Director

Peer Information
McKesson Corporation (ITRJ)
McKesson Corporation (BRLI.)
McKesson Corporation (GOGY)
McKesson Corporation (PSTX.)
McKesson Corporation (ELGXQ)
McKesson Corporation (CAH)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 58155Q103
SIC: 5122
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 125.11
Most Recent Split Date: 1.00 (2.00:1)
Beta: 0.48
Market Capitalization: $88,260.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.40%
Current Fiscal Quarter EPS Consensus Estimate: $8.58 Indicated Annual Dividend: $2.84
Current Fiscal Year EPS Consensus Estimate: $37.25 Payout Ratio: 0.09
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 13.45% Last Dividend Paid: 06/02/2025 - $0.71
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.94
Trailing 12 Months: 21.31
PEG Ratio: 1.41
Price Ratios
Price/Book: -
Price/Cash Flow: 18.15
Price / Sales: 0.25
EPS Growth
vs. Year Ago Period: 63.75%
vs. Previous Quarter: 26.03%
Sales Growth
vs. Year Ago Period: 18.95%
vs. Previous Quarter: -4.69%
ROE
06/30/25 - -
03/31/25 - -201.12
12/31/24 - -181.26
ROA
06/30/25 - -
03/31/25 - 5.83
12/31/24 - 5.34
Current Ratio
06/30/25 - -
03/31/25 - 0.90
12/31/24 - 0.88
Quick Ratio
06/30/25 - -
03/31/25 - 0.53
12/31/24 - 0.48
Operating Margin
06/30/25 - -
03/31/25 - 1.18
12/31/24 - 1.09
Net Margin
06/30/25 - -
03/31/25 - 0.92
12/31/24 - 0.82
Pre-Tax Margin
06/30/25 - -
03/31/25 - 1.21
12/31/24 - 1.16
Book Value
06/30/25 - -
03/31/25 - -13.52
12/31/24 - -21.30
Inventory Turnover
06/30/25 - -
03/31/25 - 14.32
12/31/24 - 13.99
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©